EN

Beyond mutations.

Towards functional precision.


Unlocking therapeutic targets with patient-derived organoids and high-throughput functional genomics.

News Center

  • Double Honors! Nanjing Zewei Biotech's Organoid Technology Earns Industry Recognition.

    In March 2025, the 5th Organoid Congress—themed "Organoids and Innovative Drug Discovery & Development"—was grandly 
    held in Shanghai. Nanjing Zewei Biotechnology Co., Ltd. stood out in the selection process with its groundbreaking innovations in 
    organoid technology, clinching two distinguished honors: the "Technology Breakthrough Award" and the "Best Popularity  Award”.


    56 2025-03-13